Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Sci Rep ; 14(1): 6876, 2024 03 22.
Article in English | MEDLINE | ID: mdl-38519579

ABSTRACT

Hydatidiform moles are abnormal conceptuses. Many hydatidiform moles are diploid androgenetic, and of these, most are homozygous in all loci. Additionally, most hydatidiform moles are euploid. Using Single Nucleotide Polymorphism (SNP) array analysis, in two studies a higher frequency of aneuploidy was observed in diploid androgenetic heterozygous conceptuses, than in their homozygous counterparts. In the Danish Mole Project, we analyze conceptuses suspected to be hydatidiform moles due to the clinical presentation, using karyotyping and Short Tandem Repeat (STR) analysis. Among 278 diploid androgenetic conceptuses, 226 were homozygous in all loci and 52 (18.7%) were heterozygous in several loci. Among 142 triploid diandric conceptuses, 141 were heterozygous for paternally inherited alleles in several loci. Here we show that the frequencies of aneuploidy in diploid androgenetic heterozygous and triploid diandric heterozygous conceptuses were significantly higher than the frequency of aneuploidy in diploid androgenetic homozygous conceptuses. In diploid androgenetic and triploid diandric conceptuses that are heterozygous for paternally inherited alleles, the two paternally inherited sets of genomes originate in two spermatozoa. Each spermatozoon provides one pair of centrioles to the zygote. The presence of two pairs of centrioles may cause an increased risk of aneuploidy.


Subject(s)
Hydatidiform Mole , Uterine Neoplasms , Male , Pregnancy , Female , Humans , Diploidy , Triploidy , Hydatidiform Mole/genetics , Heterozygote , Aneuploidy
2.
Clin Genet ; 93(4): 860-869, 2018 04.
Article in English | MEDLINE | ID: mdl-29194579

ABSTRACT

Identification of fetal kidney anomalies invites questions about underlying causes and recurrence risk in future pregnancies. We therefore investigated the diagnostic yield of next-generation sequencing in fetuses with bilateral kidney anomalies and the correlation between disrupted genes and fetal phenotypes. Fetuses with bilateral kidney anomalies were screened using an in-house-designed kidney-gene panel. In families where candidate variants were not identified, whole-exome sequencing was performed. Genes uncovered by this analysis were added to our kidney panel. We identified likely deleterious variants in 11 of 56 (20%) families. The kidney-gene analysis revealed likely deleterious variants in known kidney developmental genes in 6 fetuses and TMEM67 variants in 2 unrelated fetuses. Kidney histology was similar in the latter 2 fetuses-presenting a distinct prenatal form of nephronophthisis. Exome sequencing identified ROBO1 variants in one family and a GREB1L variant in another family. GREB1L and ROBO1 were added to our kidney-gene panel and additional variants were identified. Next-generation sequencing substantially contributes to identifying causes of fetal kidney anomalies. Genetic causes may be supported by histological examination of the kidneys. This is the first time that SLIT-ROBO signaling is implicated in human bilateral kidney agenesis.


Subject(s)
Kidney Diseases/genetics , Neoplasm Proteins/genetics , Nerve Tissue Proteins/genetics , Prenatal Diagnosis , Receptors, Immunologic/genetics , Autopsy , DNA Mutational Analysis , Female , Fetus , Genetic Predisposition to Disease , Humans , Intercellular Signaling Peptides and Proteins/genetics , Kidney Diseases/physiopathology , Male , Membrane Proteins/genetics , Mutation/genetics , Exome Sequencing , Roundabout Proteins
3.
Hum Reprod ; 32(8): 1684-1700, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28854595

ABSTRACT

STUDY QUESTION: Do specific transcriptome dynamics in human oocytes from primordial and primary follicles identify novel pathways in oocyte activation? SUMMARY ANSWER: The transcriptomic profiles in oocytes from primordial and primary follicles, respectively, revealed several new canonical pathways as putative mediators of oocyte dormancy and activation. WHAT IS KNOWN ALREADY: Cellular signaling pathways including PI3K/AKT and AKT/mTOR as well as TGF-ß and IGF signaling are known to regulate the primordial-to-primary transition in mammalian follicle development. STUDY DESIGN, SIZE, DURATION: We performed a class comparison study on human oocytes from primordial (n = 436) and primary (n = 182) follicles donated by three women having ovarian tissue cryopreserved before chemotherapy. PARTICIPANTS/MATERIALS, SETTING, METHODS: RNA was extracted from oocytes from primordial and primary follicles isolated by Laser Capture Microdissection, and submitted to the HiSeq Illumina platform. Data mapping, quality control, filtering and expression analysis were performed using Tophat (2.0.4), Cufflinks (2.0.2), BWA (0.6.2) and software R. Modeling of complex biological systems was performed using the IPA® software. Finally, qPCR and immunohistochemistry were employed to explore expression and localization of selected genes and products in human ovarian tissue. MAIN RESULTS AND THE ROLE OF CHANCE: We found 223 and 268 genes down-regulated and up-regulated, respectively, in the oocytes during the human primordial-to-primary follicle transition (P < 0.05 and/or FPKM fold-change >2). IPA® enrichment analysis revealed known pathways ('mTOR Signaling', 'PI3K/AKT Signaling' and 'PTEN Signaling') as well as enriched canonical pathways not previously associated with human ovarian follicle development such as 'ErB Signaling' and 'NGF Signaling' in the down-regulated category and 'Regulation of eIF4 and P70S6K Signaling' and 'HER-2 Signaling in Breast Cancer' in the up-regulated group. Additionally, immunohistochemistry on human ovarian tissue explored the intraovarian localization of VASA, FOXO1 and eIF4E. LARGE SCALE DATA: http://users-birc.au.dk/biopv/published_data/ernst_2017/. LIMITATIONS, REASONS FOR CAUTION: This is a descriptive analysis and no functional studies were performed. The study was based on a limited number of patients and the experimental design could not take into account the natural biological variance in human samples. Therefore, qPCR was used to confirm selected genes alongside immunohistochemical stainings. WIDER IMPLICATIONS OF THE FINDINGS: This study shows, for the first time, a detailed molecular description of global gene transcription activities in oocytes from primordial and primary follicles, respectively. Knowing the global transcription profiles of human oocyte dormancy and activation are important in developing new clinical applications. STUDY FUNDING/COMPETING INTEREST(S): E.H.E. was supported by Health Faculty, Aarhus University and Kong Christian Den Tiendes Fond. K.H. and S.F. were supported by an MRC (UK) project grant MR/M012638/1. K.L.H. was supported by grants from Fonden til Lægevidenskabens Fremme, Kong Christian Den Tiendes Fond. K.L.H. and L.S. were supported by the IDEAS grant from Aarhus University Research Foundation (AUFF). There are no conflicts of interest.


Subject(s)
Oocytes/metabolism , Oogenesis/physiology , Ovarian Follicle/metabolism , Signal Transduction/physiology , Transcriptome , Female , Humans , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , TOR Serine-Threonine Kinases/metabolism
4.
Int J Colorectal Dis ; 31(5): 997-1004, 2016 May.
Article in English | MEDLINE | ID: mdl-26979979

ABSTRACT

PURPOSE: In this paper, we aimed to collect genetic and medical information on all Danish patients with Peutz-Jeghers syndrome (PJS), in order to contribute to the knowledge of phenotype and genotype. Peutz-Jeghers syndrome is a hereditary syndrome characterized by multiple hamartomatous polyps in the GI tract, mucocutaneous pigmentations, and an increased risk of cancer in the GI tract and at extraintestinal sites. Over 90 % of patients harbour a pathogenic mutation in STK11. METHODS: Based on the Danish Pathology Data Bank, the Danish National Patient Register, as well as information from relevant departments at Danish hospitals, we identified patients and collected clinical and genetic information. RESULTS: We identified 43 patients of which 14 were deceased. The prevalence was estimated to be ∼1 in 195,000 individuals. The median age at first symptom was 27.5 with invagination of the small bowel as the most frequent presenting symptom. We noted 18 occurrences of cancer at various anatomical sites, including a case of thyroid cancer and penile cancer. Eight of the deceased patients had died of cancer. Eighteen different mutations in STK11 had been detected in 28 patients. CONCLUSION: This is the first comprehensive study of patients with Peutz-Jeghers syndrome in the Danish population identified from nationwide registers and databases. We have demonstrated that the expressivity of Peutz-Jeghers syndrome varies greatly among the patients, even within the same families, underlining the great phenotypic spectrum. Patients with PJS should be offered surveillance from childhood in order to prevent morbidity and reduce mortality.


Subject(s)
Peutz-Jeghers Syndrome/diagnosis , Peutz-Jeghers Syndrome/pathology , AMP-Activated Protein Kinase Kinases , Adult , Aged , Aged, 80 and over , Cause of Death , Denmark/epidemiology , Female , Humans , Male , Middle Aged , Mutation/genetics , Neoplasms/pathology , Peutz-Jeghers Syndrome/epidemiology , Polyps/pathology , Population Surveillance , Prevalence , Protein Serine-Threonine Kinases/genetics , Young Adult
5.
Clin Genet ; 88(3): 267-72, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25225168

ABSTRACT

We report four previously undescribed families with germline BRCA1-associated protein-1 gene (BAP1) mutations and expand the clinical phenotype of this tumor syndrome. The tumor spectrum in these families is predominantly uveal malignant melanoma (UMM), cutaneous malignant melanoma (CMM) and mesothelioma, as previously reported for germline BAP1 mutations. However, mutation carriers from three new families, and one previously reported family, developed basal cell carcinoma (BCC), thus suggesting inclusion of BCC in the phenotypic spectrum of the BAP1 tumor syndrome. This notion is supported by the finding of loss of BAP1 protein expression by immunochemistry in two BCCs from individuals with germline BAP1 mutations and no loss of BAP1 staining in 53 of sporadic BCCs consistent with somatic mutations and loss of heterozygosity of the gene in the BCCs occurring in mutation carriers. Lastly, we identify the first reported recurrent mutation in BAP1 (p.R60X), which occurred in three families from two different continents. In two of the families, the mutation was inherited from a common founder but it arose independently in the third family.


Subject(s)
Carcinoma, Basal Cell/genetics , Genetic Predisposition to Disease , Germ-Line Mutation , Tumor Suppressor Proteins/genetics , Ubiquitin Thiolesterase/genetics , Carcinoma, Basal Cell/metabolism , DNA Mutational Analysis , Female , Haplotypes , Heterozygote , Humans , Loss of Heterozygosity , Male , Pedigree , Polymorphism, Single Nucleotide , Tumor Suppressor Proteins/metabolism , Ubiquitin Thiolesterase/metabolism
6.
Mol Hum Reprod ; 19(11): 773-81, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23963444

ABSTRACT

Women with mutation in both alleles of the NLRP7 or C6orf221/KHDC3L genes are predisposed to diploid biparental moles, but it has also been suggested that mutation in these genes can predispose to diploid androgenetic or triploid moles and to other kinds of reproductive wastage. We have investigated the association between molar pregnancy and recurrent miscarriages regarding changes in the NLRP7 and C6orf221/KHDC3L genes. Our study group can be divided into three sub-cohorts: (i) women having had at least one molar pregnancy and at least two non-mole miscarriages, (ii) women having had recurrent androgenetic hydatidiform moles and (iii) women having had one diploid androgenetic hydatidiform mole and a relative having had a hydatidiform mole (familial hydatidiform moles). We observed a statistically non-significant tendency of non-synonymous variants in NLRP7 to be more frequent in women with familial hydatidiform mole and in women with female family members with hydatidiform mole or non-mole miscarriage compared with women with no family history of mole or miscarriage. However, we did not find any unequivocal pathogenic mutations (the term 'unequivocal pathogenic mutations' refers to mutations that indubitably have a pathogenic effect on the affected woman) in NLRP7 or C6orf221/KHDC3L in any of the women in the study group. This indicates that recurrent miscarriages plus hydatidiform mole, recurrent androgenetic hydatidiform moles and familial androgenetic hydatidiform moles in general do not have the same monogenetic etiology as familiar diploid biparental moles.


Subject(s)
Abortion, Habitual/genetics , Adaptor Proteins, Signal Transducing/genetics , Hydatidiform Mole/genetics , Proteins/genetics , Abortion, Habitual/epidemiology , Cohort Studies , DNA Mutational Analysis , Denmark/epidemiology , Family , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Hydatidiform Mole/epidemiology , Polymorphism, Single Nucleotide , Pregnancy
7.
Prenat Diagn ; 33(12): 1131-6, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23881788

ABSTRACT

OBJECTIVE: When a triploid pregnancy is diagnosed prenatally, gynaecologists have traditionally relied on the histopathological examination of the tissue from the terminated pregnancy to determine if the pregnancy is molar. However, reproducibility is poor and variability is high when diagnosing hydatidiform moles. Triploid pregnancies can have either the chromosomal constitution of two maternal and one paternal set, or two paternal and one maternal set, but only the conceptuses with two paternal sets have the potential to cause maternal complications. Therefore, it would be beneficial to introduce a method that gives the gynaecologist the parental origin of the genome of the triploid conceptus as early as possible, without delaying the process by first collecting parental samples. METHODS: Using methylation-specific multiplex ligation-dependent probe amplification, we measured methylation levels at different imprinted sites. RESULTS: We were able to correctly determine the parental origin of the genome in all 105 triploid pregnancies analysed. CONCLUSIONS: We present methylation-specific multiplex ligation-dependent probe amplification as a method capable of determining the parental origin of the genome of triploid conceptuses within 24 h; it is inexpensive, simple and easy to use, and parental samples are not needed.


Subject(s)
DNA Methylation/genetics , Hydatidiform Mole/genetics , Multiplex Polymerase Chain Reaction , Parents , Prenatal Diagnosis/methods , Triploidy , Female , Humans , Hydatidiform Mole/diagnosis , Karyotyping , Male , Pregnancy , Pregnancy Complications/genetics , Reproducibility of Results , Risk Factors , Uterine Neoplasms/genetics
8.
Mol Hum Reprod ; 18(12): 593-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22909446

ABSTRACT

Hydatidiform moles (HMs) most often occur sporadically and are either diploid androgenetic or triploid. The very rare familial recurrent HMs (FRHMs) have been related to NLRP7 and C6orf221 mutations in the mother. FRHMs are most often diploid with both maternal and paternal origin of the molar genome. We have screened a cohort of 11 women with diploid HMs with biparental contributions to the molar genome with regard to mutations in NLRP7, NLRP2, the NLRP gene most homologous to NLRP7, and C6orf221. This was done in order to reveal if mutations in the mentioned genes play a major role in development of non-recurrent biparental moles. Recently, we have shown that eight of these diploid moles consist of two different cell lines. Only one woman had a mutation in the coding DNA sequence of NLRP7, which most likely contributed to HM development. This woman had non-mosaic repeated moles, and she was the only woman in our cohort with FRHM. We found no unequivocal pathogenic mutations in NLRP2 or C6orf221. Our observations suggest that although NLRP7 and C6orf221 mutations are related to diploid biparental FRHMs, neither of these genes, nor NLRP2, are related to diploid HMs with biparental contributions to the molar genome, in general.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Hydatidiform Mole/etiology , Hydatidiform Mole/genetics , Proteins/genetics , Apoptosis Regulatory Proteins , Diploidy , Female , Humans , Mutation , Pregnancy
9.
Mol Hum Reprod ; 17(6): 379-85, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21257601

ABSTRACT

Previously, siblings of patients with idiopathic recurrent miscarriage (IRM) have been shown to have a higher risk of miscarriage. This study comprises two parts: (i) an epidemiological part, in which we introduce data on the frequency of miscarriage among 268 siblings of 244 patients with IRM and (ii) a genetic part presenting data from a genome-wide linkage study of 38 affected sibling pairs with IRM. All IRM patients (probands) had experienced three or more miscarriages and affected siblings two or more miscarriages. The sibling pairs were genotyped by the Affymetrix GeneChip 50K XbaI platform and non-parametric linkage analysis was performed via the software package Merlin. We find that siblings of IRM patients exhibit a higher frequency of miscarriage than population controls regardless of age at the time of pregnancy. We identify chromosomal regions with LOD scores between 2.5 and 3.0 in subgroups of affected sibling pairs. Maximum LOD scores were identified in four occurrences: for rs10514716 (3p14.2) when analyzing sister-pairs only; for rs10511668 (9p22.1) and rs341048 (11q13.4) when only analyzing families where the probands have had four or more miscarriages; and for rs10485275 (6q16.3) when analyzing one sibling pair from each family only. We identify no founder mutations. Concluding, our results imply that IRM patients and their siblings share factors which increase the risk of miscarriage. In this first genome-wide linkage study of affected sibling pairs with IRM, we identify regions on chromosomes 3, 6, 9 and 11 which warrant further investigation in order to elucidate their putative roles in the genesis of IRM.


Subject(s)
Abortion, Habitual/genetics , Abortion, Habitual/epidemiology , Adolescent , Adult , Chromosome Mapping , Denmark , Female , Genetic Predisposition to Disease , Genetic Testing , Genome, Human , Genome-Wide Association Study , Genotype , Humans , Lod Score , Oligonucleotide Array Sequence Analysis , Pregnancy , Risk Factors , Siblings , Software
10.
Clin Genet ; 79(5): 431-7, 2011 May.
Article in English | MEDLINE | ID: mdl-21199491

ABSTRACT

This study aims to evaluate the incidence of breast cancer after risk-reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long-term follow-up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk-reducing bilateral salpingo-oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post-mastectomy breast cancer was 0.8% compared with 1.7% in the non-operated group. Implications of these findings in relation to genetic counseling and future management are discussed.


Subject(s)
Breast Neoplasms/surgery , Mastectomy/methods , Adult , Aged , Aged, 80 and over , Breast Neoplasms/epidemiology , Breast Neoplasms/genetics , Female , Genes, BRCA1 , Genes, BRCA2 , Humans , Middle Aged , Mutation , Risk Reduction Behavior , Young Adult
11.
Clin Genet ; 77(4): 342-9, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20059483

ABSTRACT

Once female carriers of a BRCA mutation are identified they have to make decisions on risk management. The aim of this study is to outline the uptake of risk-reducing surgery in the Danish population of BRCA mutation positive women and to search for factors affecting this decision. We analysed data from 306 healthy BRCA carriers with no personal history of ovarian or breast cancer. We found a 10-year uptake of 75% for risk-reducing salpingo-oophorectomy and 50% for risk-reducing mastectomy by time to event analysis. Age and childbirth influenced this decision. The uptake rate has not changed significantly over the last decade. Risk-reducing surgeries are widely acceptable among Danish BRCA mutation positive women and the uptake of prophylactic mastectomy is higher than in most other countries.


Subject(s)
BRCA1 Protein/genetics , BRCA2 Protein/genetics , Fallopian Tubes/surgery , Heterozygote , Mastectomy/methods , Mutation/genetics , Ovariectomy/methods , Adult , Aged , Female , Humans , Middle Aged , Risk Factors , Time Factors
12.
J Med Genet ; 44(11): 702-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17873119

ABSTRACT

BACKGROUND: In patients with juvenile polyposis syndrome (JPS) the frequency of large genomic deletions in the SMAD4 and BMPR1A genes was unknown. METHODS: Mutation and phenotype analysis was used in 80 unrelated patients of whom 65 met the clinical criteria for JPS (typical JPS) and 15 were suspected to have JPS. RESULTS: By direct sequencing of the two genes, point mutations were identified in 30 patients (46% of typical JPS). Using MLPA, large genomic deletions were found in 14% of all patients with typical JPS (six deletions in SMAD4 and three deletions in BMPR1A). Mutation analysis of the PTEN gene in the remaining 41 mutation negative cases uncovered a point mutation in two patients (5%). SMAD4 mutation carriers had a significantly higher frequency of gastric polyposis (73%) than did patients with BMPR1A mutations (8%) (p<0.001); all seven cases of gastric cancer occurred in families with SMAD4 mutations. SMAD4 mutation carriers with gastric polyps were significantly older at gastroscopy than those without (p<0.001). In 22% of the 23 unrelated SMAD4 mutation carriers, hereditary hemorrhagic telangiectasia (HHT) was also diagnosed clinically. The documented histologic findings encompassed a wide distribution of different polyp types, comparable with that described in hereditary mixed polyposis syndromes (HMPS). CONCLUSIONS: Screening for large deletions raised the mutation detection rate to 60% in the 65 patients with typical JPS. A strong genotype-phenotype correlation for gastric polyposis, gastric cancer, and HHT was identified, which should have implications for counselling and surveillance. Histopathological results in hamartomatous polyposis syndromes must be critically interpreted.


Subject(s)
Bone Morphogenetic Protein Receptors, Type I/genetics , Chromosome Deletion , Gastrointestinal Neoplasms/genetics , Intestinal Polyposis/genetics , Neoplastic Syndromes, Hereditary/genetics , PTEN Phosphohydrolase/genetics , Smad4 Protein/genetics , Adolescent , Adult , Age of Onset , Antigens, CD , Bone Morphogenetic Protein Receptors, Type I/deficiency , Cadherins/genetics , Child , Child, Preschool , DNA Mutational Analysis , Female , Gastrointestinal Neoplasms/epidemiology , Genetic Heterogeneity , Genotype , Germany/epidemiology , Humans , Infant , Intestinal Polyposis/epidemiology , Male , Neoplastic Syndromes, Hereditary/epidemiology , Nucleic Acid Amplification Techniques , PTEN Phosphohydrolase/deficiency , Phenotype , Point Mutation , Smad4 Protein/deficiency , Telangiectasia, Hereditary Hemorrhagic/epidemiology , Telangiectasia, Hereditary Hemorrhagic/genetics
13.
BJOG ; 114(10): 1273-7, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17655732

ABSTRACT

OBJECTIVE: To describe and compare the current clinical features of diploid and triploid molar pregnancy and to evaluate whether the presenting clinical features can predict the ploidy of a molar pregnancy. DESIGN: A retrospective study of the clinical features and ploidy of hydatidiform moles. SETTING: The Departments of Clinical Genetics and Pathology, Aarhus University Hospital and 13 gynaecological wards, Jutland, Denmark. POPULATION: A total of 259 women with molar pregnancy diagnosed between April 1986 and June 2003. METHODS: A review of medical records of consecutively collected, clinically suspected cases of molar pregnancy was performed. The molar ploidy was determined by karyotyping, flow cytometry, and/or analysis of polymorphic DNA markers. MAIN OUTCOME MEASURES: Maternal characteristics, presenting symptoms, initial human chorionic gonadotrophin (hCG), and molar ploidy. RESULTS: In a multiple logistic regression model, initial hCG of > or = 100,000 iu/l (P < 0.001), first-trimester gestational age (P < 0.001), vaginal bleeding (P < 0.001), and maternal age of > or = 40 years (P = 0.03) were independent predictors of diploid mole. Women with excessive uterine size more frequently had a diploid than a triploid mole (P < 0.001). Fifty-four percent of the women with triploid mole and 27% of the women with diploid mole were diagnosed before onset of symptoms (P < 0.001). CONCLUSIONS: The current clinical features of diploid mole are different from those of triploid mole. The presenting clinical profile of a molar pregnancy may be used as an early predictor of the molar ploidy and thus of the prognosis.


Subject(s)
Hydatidiform Mole/genetics , Ploidies , Uterine Neoplasms/genetics , Adolescent , Adult , Chorionic Gonadotropin/metabolism , Female , Gravidity , Humans , Hydatidiform Mole/blood , Hydatidiform Mole/pathology , Logistic Models , Middle Aged , Pregnancy , Retrospective Studies , Uterine Hemorrhage/etiology , Uterine Neoplasms/blood , Uterine Neoplasms/pathology
14.
Acta Paediatr ; 93(3): 419-21, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15124852

ABSTRACT

UNLABELLED: Barth syndrome involves cardiomyopathy, skeletal myopathy, neutropenia and 3-methylglutaconic (3-mgc) aciduria. 3-mgc aciduria has been observed in almost all reported cases and has served as a diagnostic criterion. CONCLUSION: A case of confirmed BTHS, but without 3-mgc aciduria, emphasizes the importance of extensive investigations in cases with suspected hereditary cardiomyopathy.


Subject(s)
Cardiomyopathies/genetics , Muscular Diseases/genetics , Mutation, Missense , Arginine/genetics , Cardiomyopathies/diagnosis , Chromosomes, Human, X , Fatal Outcome , Glutarates , Glycine/genetics , Humans , Infant, Newborn , Male , Muscular Diseases/diagnosis , Mutation , Pedigree , Syndrome
15.
Eur J Hum Genet ; 9(11): 823-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11781698

ABSTRACT

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations to the TSC1 and TSC2 tumour suppressor genes. We detected two sequence changes involving the TSC2 stop codon and investigated the effects of these changes on the expression of tuberin, the TSC2 gene product, and on the binding between tuberin and the TSC1 gene product, hamartin. While elongation of the tuberin open reading frame by 17 amino acids did not interfere with tuberin-hamartin binding, a longer extension prevented this interaction. Our data illustrate how functional protein assays can assist in the verification and characterisation of disease-causing mutations.


Subject(s)
Codon, Terminator/genetics , Repressor Proteins/genetics , Tuberous Sclerosis/genetics , Animals , COS Cells , Family Health , Female , Genetic Variation , Humans , Male , Mutation , Pedigree , Protein Binding , Proteins/genetics , Proteins/metabolism , Repressor Proteins/metabolism , Saccharomyces cerevisiae/genetics , Tuberous Sclerosis/pathology , Tuberous Sclerosis Complex 1 Protein , Tuberous Sclerosis Complex 2 Protein , Tumor Suppressor Proteins , Two-Hybrid System Techniques
16.
Placenta ; 21(8): 754-62, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11095924

ABSTRACT

Urokinase plasminogen activator, its receptor and the inhibitor PAI-1 are believed to control proteolysis and remodelling of maternal tissue during trophoblast invasion. This system appears to be strictly regulated in normal intrauterine pregnancies whereas tubal and molar pregnancies seem to be characterized by an uncontrolled excessive placental invasion. This study evaluates subcellular PAI-1 by immunohistochemistry in the villous placenta, in the basal plate and placental bed, and in the decidual compartments of normal, tubal and molar pregnancies. PAI-1 was present in villous syncytiotrophoblasts and co-localized focally with fibrin-type fibrinoid on the surface of the chorionic villi. Basal plate and placental bed extravillous interstitial trophoblasts, as well as vascular trophoblasts, were also PAI-1 positive. In the decidua parietalis, PAI-1 was observed in the cytoplasm of the non-invaded decidual cells. In the decidua basalis comprising the basal plate, PAI-1 was seen to be membrane-associated or confined to the extracellular matrix (ECM) facing the invasive front of anchoring villi. The ECM of decidua capsularis and chorion laeve displayed the most pronounced PAI-1 expression towards the maternal interface. In contrast, the majority of placental bed decidual cells adjacent to the interstitial and vascular trophoblasts were PAI-1 negative. Only a few stromal cells distant from the implantation site were PAI-1 positive in the tubal pregnancies and decidualization was not present. Likewise, excessive decidual necrosis and fibrinoid deposition devoid of PAI-1 was a common finding in complete molar pregnancies. These results suggest that PAI-1 defines specific extravillous invasive trophoblasts within the maternal decidua. Moreover, maternal cellular lack of PAI-1 in tubal pregnancies and excessive decidual necrosis in molar pregnancies indicate an uncontrolled placental invasion. The present data indicate that trophoblast invasion is primarily regulated by signals from decidual cells.


Subject(s)
Hydatidiform Mole/metabolism , Plasminogen Activator Inhibitor 1/analysis , Pregnancy, Tubal/metabolism , Trophoblasts/chemistry , Chorionic Villi/chemistry , Decidua/chemistry , Decidua/pathology , Fallopian Tubes/chemistry , Female , Humans , Hydatidiform Mole/pathology , Immunohistochemistry , Placenta/blood supply , Placenta/chemistry , Plasminogen Activator Inhibitor 1/physiology , Pregnancy , Pregnancy, Tubal/pathology , Trophoblasts/pathology , Trophoblasts/physiology
17.
Mol Hum Reprod ; 6(10): 943-50, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11006324

ABSTRACT

Previous reports have described down-regulation of E-cadherin in trophoblasts differentiating to an invasive phenotype. This study shows the localization of E-cadherin in a prospective design with stereological sampling of fetal and maternal first, second and third trimester tissue. E-cadherin was observed in villous cytotrophoblasts, and in non-proliferating, intermediate trophoblasts (IT) within cell columns and islands in intrauterine, ectopic and partial molar placentas. Highly proliferating IT with cytological atypia in complete molar placentas were also E-cadherin-positive. E-cadherin was present in trophoblasts throughout the anchoring cell columns. Trophoblasts undergoing epithelial mesenchymal transformation (EMT) detaching from the distal cell columns and deeper located single extravillous interstitial trophoblasts (EVT) showed E-cadherin-negative breaches in the cell membrane. Prior to the late second trimester, the relative number of E-cadherin-positive single EMT and EVT differed from the total number of cytokeratin-positive trophoblasts. Intraluminal, endovascular and perivascular trophoblasts adjacent to the maternal vessels were also E-cadherin-positive, but a highly varying pattern was observed at different ages of gestation. Our results indicate a temporary shift in E-cadherin expression in extravillous trophoblasts possessing a migrating and invasive potential. Functional E-cadherin may be restored as trophoblasts aggregate in the decidua and the vessel wall after completion of migration.


Subject(s)
Cadherins/analysis , Hydatidiform Mole/metabolism , Placenta/chemistry , Pregnancy, Ectopic/metabolism , Trophoblasts/chemistry , Antibodies, Monoclonal , Cadherins/immunology , Endometrium/chemistry , Endometrium/cytology , Endothelium, Vascular/chemistry , Endothelium, Vascular/cytology , Fallopian Tubes/blood supply , Female , Humans , Placenta/cytology , Pregnancy , Pregnancy Trimesters , Prospective Studies , RNA, Messenger/analysis , Trophoblasts/cytology
18.
Differentiation ; 66(1): 49-59, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10997592

ABSTRACT

Fetal antigen 1 (FA1) is a circulating EGF multidomain glycoprotein. FA1 and its membrane-associated precursor is defined by the mRNAs referred to as delta-like (dlk), preadipocyte factor 1 (pref-1) or zona glomerulosa-specific factor (ZOG). Using a polyclonal antibody recognising both forms, the localisation of FA1/dlk was analysed in embryonic and fetal tissues between week 5 to 25 of gestation and related to germinal origin and development. FA1 was observed in endodermally derived hepatocytes, glandular cells of the pancreas anlage, and in respiratory epithelial cells. FA1 was also present in mesodermally derived cells of the renal proximal tubules, adrenal cortex, Leydig and Hilus cells of the testes and ovaries, fetal chondroblasts, and skeletal myotubes. Ectodermally derived neuro- and adenohypophysial cells, cells in the floor of the 3rd ventricle and plexus choroideus were also FA1 positive. The number of cells expressing FA1 decreased during fetal development where the expression became restricted to specific functional cells. Epidermis, gut epithelium, gall bladder, blood cells, spleen, thyroid gland, salivary glands, and smooth muscle cells were FA1 negative. Analysis of extra-embryonic tissues from normal and pathological pregnancies revealed FA1 in stromal cells surrounding the blood islands of the yolk sac as well as in placental fibroblasts where the expression was most pronounced in diploid, androgenic complete hydatidiform moles. However, as measured by ELISA, the circulating maternal FA1 levels in complete moles were not different from normal pregnancies. The results presented suggest that FA1 is a growth and/or differentiation factor extensively expressed in immature cells and down-regulated during fetal development. FA1 down-regulation was associated with a shift in the subcellular localisation indicating differential post-translational/post-transcriptional modifications during fetal development. FA1 may be a new marker of cellular subtypes with a regenerative potential and of specific cells with endocrine or neuroendocrine functions.


Subject(s)
Embryo, Mammalian/blood supply , Embryo, Mammalian/metabolism , Endocrine System/metabolism , Glycoproteins/metabolism , Placental Circulation , Regeneration , Biomarkers/analysis , Biomarkers/blood , Ectoderm/metabolism , Embryo, Mammalian/chemistry , Embryo, Mammalian/cytology , Endoderm/metabolism , Female , Fetus/blood supply , Fetus/chemistry , Fetus/cytology , Fetus/metabolism , Glycoproteins/analysis , Glycoproteins/blood , Humans , Immunohistochemistry , Mesoderm/metabolism , Molecular Sequence Data , Placenta/blood supply , Placenta/chemistry , Placenta/cytology , Placenta/metabolism , Pregnancy
19.
Eur J Hum Genet ; 8(5): 393-5, 2000 May.
Article in English | MEDLINE | ID: mdl-10854102

ABSTRACT

This report describes a mother with a balanced intrachromosomal insertion of band q22 on chromosome number 2 into band p24 on the same chromosome. She had had four spontaneous abortions and two induced abortions. One foetus had a suspected obstruction of the uretero-pelvic part of the urinary tract and monosomy of band 2q22, the other foetus had anencephaly and trisomy of band 2q22. By microdissection we have generated a painting probe from the mother's abnormal short arm of chromosome 2 (der2p probe). This family specific probe will be used in future pregnancies for precise diagnosis.


Subject(s)
Chromosome Aberrations , Chromosomes, Human, Pair 2 , Abortion, Induced , Abortion, Spontaneous , Adult , Chromosome Mapping , Female , Humans , Mutagenesis, Insertional , Pedigree
20.
Placenta ; 20(8): 711-21, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10527826

ABSTRACT

Urokinase plasminogen activator receptor (uPAR) is a membrane-anchored protein with urokinase plasminogen activator (uPA) as the ligand. This complex induces proteolysis and remodelling of maternal decidua during placental implantation. The presence of uPAR on trophoblasts is supposed to promote adhesion, migration and invasion. In cancer tissue, high levels of uPAR are correlated with a poor prognosis. This immunohistochemical study shows the localization of uPA and uPAR in a prospective design with stereological sampling of fetal and maternal tissue from normal, ectopic and hydatidiform molar (HM) pregnancies. Cytokeratin and Ki67 were used as markers for trophoblasts and proliferating cells. Membrane-bound uPAR was observed on villous non-proliferating intermediate trophoblasts (IT) within cell columns in intrauterine and ectopic pregnancies. The corresponding proliferating IT with cytological atypia sprouting from the chorionic villi in HM was uPAR-negative. uPA but not uPAR was observed in anchoring distal IT at the attachment-point to the basal plate. In the placental bed, extravillous interstitial trophoblasts were uPA-positive but uPAR-negative. The trophoblast giant cells were both uPA- and uPAR-negative. In relation to the maternal vessels, a focal distribution for uPA and uPAR was present in the endovascular and perivascular trophoblasts. The intraluminal trophoblasts overlying endothelial cells were uPAR-positive only. In maternal tissue from intrauterine and molar pregnancies, uPAR was seen in the decidual cells in a zone facing the anchoring villi and the fibrinoid lesions with embedded trophoblasts. In contrast, the stromal cells of the fallopian tube without a decidual reaction facing the implanted gestation were uPAR-negative. Non-invaded decidual, myometrial and muscular tissue of the pregnant uterus and fallopian tube was extensively positive for uPA whereas 'pseudodecidual' cells from the intrauterine evacuate in patients with an ectopic pregnancy only showed a focal and scanty reaction for uPA. When trophoblast invasion of the decidua was present, the decidual cells were uPA-negative. A semi-quantitative assessment of the receptor was estimated in villous IT within cell columns in normal and molar pregnancies but, in conclusion, quantitative evaluation of uPAR cannot be used to predict development of post-molar persistent trophoblastic disease (PTD).


Subject(s)
Hydatidiform Mole/metabolism , Placenta/chemistry , Plasminogen Activators , Pregnancy, Ectopic/metabolism , Pregnancy/metabolism , Receptors, Cell Surface/analysis , Urokinase-Type Plasminogen Activator/analysis , Chorionic Villi Sampling , Decidua/metabolism , Fallopian Tubes/metabolism , Female , Humans , Receptors, Cell Surface/physiology , Receptors, Urokinase Plasminogen Activator , Urokinase-Type Plasminogen Activator/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...